Assessment of Annona muricata Phytochemicals as 17β‐HSD1 Inhibitors through Molecular Docking, Dynamics Simulation, DFT, and ADMET Analyses
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70904 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Emad Rashad Sindi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Biochemistry, Department of Basic Medical Sciences, College of Medicine, University of Jeddah, Jeddah, Saudi Arabia. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Molecular Dynamics Simulation, Phytochemicals, Annona. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Breast cancer remains a leading cause of female mortality, largely sustained by local oestrogen production. The enzyme 17β‐hydroxysteroid dehydrogenase type 1 (17β‐HSD1) is an enzyme involved in the oestrogen biosynthesis pathway, particularly in the conversion of estrone to estradiol, and is overexpressed in conditions such as breast cancer. Therefore, it is considered a relevant target for drug development. We evaluated phytocompounds from Annona muricata as prospective 17β‐HSD1 inhibitors through an integrated in silico workflow. Twelve reported constituents (myristic acid, myrcene, palmitic acid, hexanoic acid, pentadecane, methyl 3‐phenylpropionate, butyric acid, linalool, reticuline, phytol, camphene and calamenene) were geometry‐optimised by density‐functional theory, docked against 17β‐HSD1 (PDB 3HB5), and screened for drug‐likeness and ADMET liabilities. The top‐ranked complexes—reticuline (ΔG_pred = −8.4 kcal mol −1 ) and calamenene (−7.7 kcal mol −1 )—scored more favourably than the reference epirubicin (−5.7 kcal mol −1 ) and were subjected to 100 ns molecular‐dynamics simulations. Both ligands remained stably anchored within the catalytic pocket, with root mean square deviation (RMSD) fluctuations below 2.0 Å, yet MM‐PBSA binding free energies (reticuline −27 kJ mol −1 ; calamenene −9 kJ mol −1 ) did not surpass the reference. ADMET profiling predicted acceptable Caco‐2 permeability (0.92–0.94), and only moderate hERG liability, but also signalled potential DILI and carcinogenicity alerts that warrant caution. Reticuline and calamenene fulfilled all of Lipinski's criteria, with the exception of logP in the case of calamenene. Collectively, these findings nominate reticuline and calamenene as promising lead scaffolds for selective intracellular suppression of oestrogen biosynthesis. Experimental validation (enzyme kinetics, cell‐based assays and pharmacokinetic studies) is warranted to confirm their clinical potential in oestrogen‐dependent breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Clinical Biochemistry, Department of Basic Medical Sciences, College of Medicine, University of Jeddah, Jeddah, Saudi Arabia.
- Department of Pharmacy, Islamic University, Bangladesh.
- Department of Biophysics and Pharmacology, Bioscience Center, Federal University of Rio Grande Do Norte, Natal, Brazil.
- Department of Bioinformatics and Computational Biology, Gaziantep University, Turkey.
- Department of Chemistry, Federal University of Agriculture, Abeokuta, Nigeria.
- Department of Pharmaceutical Sciences, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
ORCID-Profile: Md Jannatul Islam Polash, Guilherme Bastos Alves, Samson Olusegun Afolabi, Jonas Ivan Nobre Oliveira
Zitieren
APA
Sindi, E. R., Polash, M. J. I., Alves, G. B., Bayil, I., Afolabi, S. O., Alharbi, H. M., Khojah, A. A., Oliveira, J. I. N., Al-Mutairi, A. A., & Zaki, M. E. A. (2025). Assessment of Annona muricata Phytochemicals as 17β‐HSD1 Inhibitors through Molecular Docking, Dynamics Simulation, DFT, and ADMET Analyses. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70904
Vancouver
Sindi ER, Polash MJI, Alves GB, Bayil I, Afolabi SO, Alharbi HM, et al. Assessment of Annona muricata Phytochemicals as 17β‐HSD1 Inhibitors through Molecular Docking, Dynamics Simulation, DFT, and ADMET Analyses. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70904
BibTeX
@article{Sindi2025,
author = {Sindi, Emad Rashad and Polash, Md Jannatul Islam and Alves, Guilherme Bastos and Bayil, Imren and Afolabi, Samson Olusegun and Alharbi, Hanan M and Khojah, Alaa A and Oliveira, Jonas Ivan Nobre and Al-Mutairi, Aamal A and Zaki, Magdi E A},
title = {Assessment of Annona muricata Phytochemicals as 17β‐HSD1 Inhibitors through Molecular Docking, Dynamics Simulation, DFT, and ADMET Analyses},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70904}
}
EUVIMED